Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Current Deferred Revenue (2016 - 2025)

Pro Dex's Current Deferred Revenue history spans 10 years, with the latest figure at $163000.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue changed N/A year-over-year to $163000.0; the TTM value through Dec 2025 reached $163000.0, changed N/A, while the annual FY2025 figure was $202000.0, 1342.86% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $163000.0 at Pro Dex, up from $122000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.0 million in Q2 2022 and bottomed at $14000.0 in Q2 2024.
  • The 5-year median for Current Deferred Revenue is $247500.0 (2021), against an average of $433000.0.
  • The largest annual shift saw Current Deferred Revenue crashed 93.64% in 2023 before it soared 1342.86% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $584000.0 in 2021, then soared by 45.72% to $851000.0 in 2022, then tumbled by 93.3% to $57000.0 in 2023, then plummeted by 75.44% to $14000.0 in 2024, then soared by 1064.29% to $163000.0 in 2025.
  • Per Business Quant, the three most recent readings for PDEX's Current Deferred Revenue are $163000.0 (Q4 2025), $122000.0 (Q3 2025), and $202000.0 (Q2 2025).